MR. RALPH E WALDO, MD
Neurology at Pro-Med Ln, Carmel, IN
License number
Indiana 01057531A
Category
Psychiatric
Type
Psychiatry
License number
Indiana 71000700A
Category
Neurology
Type
Neurology
Address
Address
703 Pro-Med Ln SUITE 200, Carmel, IN 46032
Phone
(317) 843-9922
(317) 581-3918 (Fax)
(317) 581-3918 (Fax)
Organization information
See more information about RALPH E WALDO at bizstanding.comRalph E Waldo
5798 Coopers Hawk Dr, Carmel, IN 46033
Industry:
Business Services at Non-Commercial Site, Nonclassifiable Establishments
Principals:
Waldo Ralph (Principal),Waldo Radlph Principal, inactive
Professional information
Dr. Ralph E Waldo, Carmel IN - MD (Doctor of Medicine)
Specialties:
Psychiatry, Neuropsychiatry (Psychiatry)
Address:
Connected Health Care Systems
11350 N Meridian St STE 220, Carmel 46032
(317) 200-3840 (Phone)
11350 N Meridian St STE 220, Carmel 46032
(317) 200-3840 (Phone)
Certifications:
Psychiatry, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Connected Health Care Systems
11350 N Meridian St STE 220, Carmel 46032
Parkview Hospital
2200 Randalia Dr, Fort Wayne 46805
11350 N Meridian St STE 220, Carmel 46032
Parkview Hospital
2200 Randalia Dr, Fort Wayne 46805
Philosophy:
An individual considering mental health treatment often feels more apprehensive, embarrassed and vulnerable compared to a person seeking treatment for other medical conditions. Education about the underlying causes and treatment options should be completed in a sensitive, collaborative manner with the clinician, who serves as a consultant and attempts to assist the patient achieve identified goals and aspirations.
Education:
Medical School
Indiana University School Of Medicine
University Of Cinci Hosp
Indiana University School Of Medicine
University Of Cinci Hosp
Treating Adhd And Other Diseases Involving Inflammation
US Patent:
2010010, Apr 29, 2010
Filed:
Feb 5, 2008
Appl. No.:
12/527110
Inventors:
Ralph E. Waldo - Carmel IN, US
Assignee:
CONNECTED HEALTH SYSTEMS, LLC - Carmel IN
International Classification:
A61K 9/70, A61K 31/135, A61K 38/43, A61K 31/675, A61K 31/20, A61K 31/202, A61K 36/00, A61K 36/87, A61P 25/00
US Classification:
424449, 514654, 424 941, 514 89, 514558, 514560, 424725, 424766
Abstract:
The present disclosure relates to methods and drug delivery systems for treating diseases involving inflammation, including Attention Deficit Hyperactivity Disorder (ADHD) by administering a CNS stimulant to a patient in need thereof so as to maintain steady state serum drug levels that remain therapeutically effective for about 24 and ½ to about 25-27 hours or longer after administration to maintain a constant steady state between doses of medication. The method is employed to restore normal catecholamine levels throughout the day without over-stimulating or under-stimulating the patient. Additionally, the present method of treating inflamτnaτion3 including ADHD, provides, for example, dosing once a day or once a week. The present method also addresses other aspects of the disease, for example, defective P-5-P synthesis, ehminating interleukins and free radicals, and correction of Amino acids, the endocrine system and inflammation. The present systems and methods heal the brain, treat depression and ADHD, and may lower the amount of medication needed over time.